The Latest - Page 33 of 309 - Becker's Oncology

What clinicians need from AI after the pilot: Lessons from Adventist Health and Rady Children’s

Clinical AI has moved from novelty to fixture in everyday practice. The harder question now: what makes it deliver lasting value rather than stall after rollout? In this webinar, clinical and informatics leaders from Adventist Health and Rady Children’s Health…

Jul 24, 2026 12:00 PM - 1:00 PM CDT

Presented by:

Presenters:

Dr. Dieter Sumerauer, Associate Chief Health Information Officer, Rady Children’s Health
Dr. Salman Naqvi, Administrative Medical Director, Health Informatics,, Adventist
Dr. Reid Conant, Senior Physician Executive, Abridge

Abridge Keynote 2026: Patient-Centered Clinician Intelligence Platform

From the Times Center in New York City on June 6, 2026: Abridge CEO and Co-Founder Dr. Shiv Rao announced the patient-centered clinician intelligence platform—a single, horizontal intelligence layer, connecting providers, payers, and life sciences, organized around every patient, for…

On Demand

Presented by:

Presenters:

Shiv Rao, CEO & Co-Founder, Abridge
Dr. Ben Kornitzer, Chief Medical Officer, Aetna
Deanna Hanisch, Vice President & Chief Information Officer, Johns Hopkins Health System
Kimberly Powell, Kimberly Powell - Sarah Simon Kimberly Powell Vice President & General Manager, Healthcare, NVIDIA

Is ambulatory care healthcare’s big margin engine? 5 leaders weigh in

Healthcare is in the midst of a site-of-care pivot. With shrinking reimbursement, rising capital constraints and structural changes in how CMS pays for inpatient services, health system and group practice leaders are rethinking strategy and betting on ambulatory care. As…

Jul 29, 2026 1:00 PM - 2:00 PM CDT

Presented by:

Presenters:

Joe Ganley, VP of Government and Regulatory Affairs, athenahealth
Jeffrey Flynn, CASC, Administrator and Chief Operating Officer, Gramercy Surgery Center
Bryan Tsao, VP of Ambulatory Healthcare and Experience and Medical Director, Access Center, Loma Linda University Health
Jason Zepeda, Chief Operating Officer, Northridge Hospital Medical Center, CommonSpirit Health
Greg DeConciliis, PA-C, CASC, Administrator, Boston OutPatient Surgical Suites

How the CMS prior authorization deadline will expose gaps in workflows

Beginning Jan. 1, 2027, impacted health plans must exchange prior authorization data through standardized application programming interfaces (APIs). The mandate reaches Medicare Advantage organizations, state Medicaid and CHIP fee-for-service programs, managed care plans and Qualified Health Plan issuers on the…

Presented by:

AACR calls White House research funding proposal ‘reckless’: What to know

The American Association for Cancer Research has called the proposed federal grant regulations published May 29 by the White House’s Office of Management and Budget “reckless” and a “major threat” to the National Institutes of Health. “The intention of these…

Stanford, U of Michigan cancer centers offer genetic testing to patient families

Researchers at Ann Arbor-based Michigan Medicine’s Rogel Cancer Center and Stanford (Calif.) University will extend genetic testing to at-risk relatives of cancer patients with hereditary mutations. The services will be provided through a $3.2 million grant from the National Cancer…

'World-renowned' melanoma researcher dies

Richard Scolyer, MD, co-medical director of the Melanoma Institute Australia, the first patient to receive pre-surgical combination immunotherapy for glioblastoma and a “world-renowned” pathologist, died June 7 at age 59, according to a June 26 report from The New York…

Colorectal cancer screening rebounds post-pandemic: 3 notes

Colonoscopy rates have largely returned to pre-pandemic levels, but the recovery has not been equal across racial and ethnic groups, according to a study published in the Journal of the National Comprehensive Cancer Network. Researchers analyzed National Health Interview Survey…

Penn Medicine uses AI to find CAR-T targets: 3 notes

An AI framework can identify targets for CAR-T cell therapy in weeks, streamlining a process that often takes months to years, according to a study published June 25 in Cell. Here are three notes from the study: Read the full…

Dana-Farber names cancer hospital after donors

Boston-based Dana-Farber Cancer Institute’s $1.68 billion cancer hospital, currently under construction, will be named the Lavine Bekenstein Cancer Hospital at Dana-Farber. Dana-Farber President and CEO Benjamin Ebert, MD, PhD, shared the hospital’s official name June 25 on LinkedIn. The hospital…